Summary
The product ANAVAR 10, manufactured by Unique Pharma, underwent independent testing to confirm its authenticity and potency. The sample, identified by batch number UN64435, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxandrolone, with a concentration of 10.97 mg, which is +9.7% above the labeled claim of 10 mg.
The testing process began on 27 February 2024, with the sample received on 07 March 2024, and analysis completed on 08 March 2024. The results indicate the product exceeds the label claim, suggesting good quality control but warranting further investigation for consistency. This report is intended as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: ANAVAR 10
- Active Ingredient: Oxandrolone
- Batch Number: UN64435
- Expiration Date: Not provided
- Delivery Method: Oral Tablet
Sample Acquisition and Testing
- Task Number: #39492
- Testing Ordered: 27 February 2024
- Sample Received: 07 March 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 10 mg (as stated on the label)
- Measured Concentration: 10.97 mg
- Accuracy: 109.7% (+0.97 mg above label claim)
- Variance: +9.7%
Verification Details
- Verification URL: https://janoshik.com/tests/39492_7MMEVSBUK7CA
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis confirms the relative accuracy of the tested product but warrants scrutiny due to its submission and funding by the reseller Opitropin.EU. Resellers may selectively choose optimal batches for testing, which might not reflect overall market consistency. Further third-party testing across multiple batches is recommended to validate the findings comprehensively.
Conclusion
The analysis indicates that ANAVAR 10 by Unique Pharma contains 10.97 mg of Oxandrolone, exceeding the labeled claim by +9.7%, suggesting good quality control for this batch. However, further testing across different batches is crucial for consistent assurance. Consumers are advised to stay informed and rely on independent verification for purchasing decisions.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce biases; however, it still provides valuable insights when critically evaluated alongside independent third-party results. Readers are encouraged to use this information responsibly.
